ovarian cancer is one of the most common malignant neoplasms in the reproductive system of women, and despite the complexity of its occurrence, genetic factors do play an important role in the incidence of ovarian cancer. Studies have shown that ovarian cancer can be closely associated with genetic mutations, family history, etc. Patients of genetic ovarian cancer often have specific genetic mutations, which not only increase the risk of ovarian cancer, but may also have the disease at younger ages. This paper will explore the genetic, associated genes, family history and prevention and screening methods of ovarian cancer.
I. Genetic factors of ovarian cancer
About 10 to 15 per cent of ovarian cancer cases are considered genetic, in other words, genetic factors play an important role in these cases. Although most cases of ovarian cancer have no obvious family genetic background, women with family history are at a certain higher risk of disease.
The geneticity of ovarian cancer mainly involves two types: family ovarian cancer and genetic ovarian cancer caused by a specific genetic mutation. Family ovarian cancer usually manifests itself in ovarian cancer among several members of the family, but this form of genetic pattern is less explicit than that of ovarian cancer and more complex genetic factors. Genetic ovarian cancer is closely related to genetic mutation, which is the most common cause.
II. BRCA1 and BRCA2 Genetic mutations
The BRCA1 and BRCA2 genes are important genes for controlling cell growth and repairing DNA damage. The BRCA1 gene is on chromosome 17, while the BRCA2 gene is on chromosome 13. When these two genes mutate, problems arise in the cytological repair mechanisms, leading to the accumulation of DNA damage and increasing the risk of cancer. In addition to ovarian cancer, mutations of BRCA1 and BRCA2 are closely related to other cancers, such as breast cancer, prostate and pancreas.
The risk of ovarian cancer among women carrying a mutation of the BRCA1 or BRCA2 genes has increased significantly. According to statistics, the risk of ovarian cancer is about 40 to 60 per cent in the lifetime of BRCA1 mutations, while the risk of ovarian cancer is about 10 to 30 per cent in BRCA2. It is therefore particularly important for women carrying the BRCA gene mutation to take preventive measures at an early stage.
Lynch syndrome and ovarian cancer
Lynch Syndrome (Lynch Syndrome), also known as Genetic Insistence Constituent Carcinoma (HNPCC), is a common genetic cancer syndrome, with patients usually suffering from colon cancer at younger ages, intrauterine cancer, ovarian cancer, etc. Lynch’s syndrome is MLH 1, MSH
2. MSH
The mutations of genes such as 6 and PMS2 are closely related to the DNA repair process. Women with Lynch syndrome are more likely to develop into ovarian cancer than the general population.
Unlike the BRCA gene mutation, Lynch’s syndrome, although it also increases the risk of ovarian cancer, has a major effect on colon and uterine cancer. The risk of ovarian cancer for Lynch is usually between 10 and 20 per cent.
IV. Family history and genetic background of ovarian cancer
Family history is an important risk factor for ovarian cancer. Women with ovarian cancer are at higher risk of cancer among their immediate family members (mother, sister, daughter) than the general population. If many members of the family have ovarian cancer or associated cancer (e.g. breast cancer, uterine, colon cancer, etc.), the family member is more likely to have ovarian cancer.
However, not all ovarian cancers with family history are genetic ovarian cancers, and in many cases family history may be due only to accidental cancer patterns. As a result, family history, while an important reminder of ovarian cancer, does not necessarily mean that it will be inherited from the next generation.
V. Screening and prevention of ovarian cancer
Regular ovarian cancer screening and preventive measures are essential for women who have family history or are known to carry a mutation of the BRCA 1 and BRCA2 genes. Existing ovarian cancer screening methods include ultrasound screening and sero-tumour marker detection (e.g. CA-125). However, there is currently no screening method that can effectively detect ovarian cancer at an early stage, and doctors usually recommend more proactive preventive measures for high-risk women.
1. Genetic testing: For women with family history, particularly those with immediate family members who have had ovarian or breast cancer, genetic testing can help to determine if they are carrying a BRCA gene mutation. If the results are positive, the risk of cancer can be reduced by measures such as regular screening, preventive ovarian or breast removal.
2. Preventive surgery: Preventive ovarian and mammography can significantly reduce the risk of cancer among women at high risk, especially those with a BRCA gene mutation. Although these operations are irreversible, they are an effective means of prevention for women who fear cancer.
3. Drug prevention: Certain drugs, such as mosaics or aromatic enzymes inhibitors, may have the effect of preventing ovarian cancer for certain women at high risk, especially for the BRCA gene mutations. However, the preventive effects of these drugs still require further study and validation.
Concluding remarks
In general, ovarian cancer has some genetic properties, in particular those such as BRCA 1, BRCA2 gene mutations and Lynch syndrome, which significantly increase the risk of ovarian cancer. However, only a small number of cases of ovarian cancer are directly related to genetic factors, most of which are due to a combination of environmental and lifestyle factors. It is therefore important for women with family history or known genetic mutations to undertake genetic testing, periodic screening and corresponding preventive measures. Early detection and active intervention can effectively reduce the risk of ovarian cancer and improve patient prognosis.
